
Speaker Dr. Alice Limonciel
Affiliation biocrates life sciences
Metabolomics – a phenotypic crossroad
In this webinar, biocrates senior scientist Alice Limonciel shares information about
- Depression has an impact on nitric oxide synthesis, urea cycle, inflammation, and ADMA levels.
- The Western-style diet may contribute to depression by shifting the balance between primary and secondary bile acids, leading to mitochondrial dysfunction and oxidative stress, which inhibits DDAH and leads to the accumulation of ADMA.
- Understanding the metabolic changes in depressive disorders can lead to potential drug targets, such as addressing ADMA levels.
- Connecting the disease to society and diet can help explain the increasing burden of depression globally and find better ways to help patients.
- Empathy for those living with depression is important, and understanding the biology and metabolome better can help us progress in the right direction.
Related articles
- Transform medicine with metabolomics – Preventive medicine – part 1 of 5
- Citric acid – Key metabolite in energy production, bone health, and disease therapy
- Precision nutrition – Unlocking health through metabolomics
- Oxaloacetic acid (OAA) – Key metabolite in metabolism, disease, and therapeutic innovation
- Introduction to metabolomics in action